Tarsus Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TARS and other ETFs, options, and stocks.About TARS
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis.
TARS Key Statistics
Stock Snapshot
Tarsus Pharmaceuticals(TARS) stock is priced at $75.01, giving the company a market capitalization of 3.21B. It carries a P/E multiple of -46.92.
On 2026-03-02, Tarsus Pharmaceuticals(TARS) shares started trading at $75.75, with intraday highs of — and lows of —.
Trading volume for Tarsus Pharmaceuticals(TARS) stock has reached 0, versus its average volume of 881.78K.
The stock's 52-week range extends from a low of $38.51 to a high of $85.25.
The stock's 52-week range extends from a low of $38.51 to a high of $85.25.
Analyst ratings
100%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.